Access to anti-retroviral drugs, female in Greece
Greece: Access to anti-retroviral drugs, female was 57.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, female in Greece, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Greece recorded 57.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
That represents a change of up 1.8% on the previous year and up 16.3% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Greece peaked at 57.0% in 2024 and was at its lowest, 42.0%, in 2010.
Greece ranks 108th of 141 countries on this measure, in the bottom quarter.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, female in Greece, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 45.0% | — |
| 2001 | 47.0% | +4.4% |
| 2002 | 46.0% | -2.1% |
| 2003 | 45.0% | -2.2% |
| 2004 | 44.0% | -2.2% |
| 2005 | 44.0% | +0.0% |
| 2006 | 43.0% | -2.3% |
| 2007 | 43.0% | +0.0% |
| 2008 | 43.0% | +0.0% |
| 2009 | 43.0% | +0.0% |
| 2010 | 42.0% | -2.3% |
| 2011 | 43.0% | +2.4% |
| 2012 | 45.0% | +4.7% |
| 2013 | 47.0% | +4.4% |
| 2014 | 49.0% | +4.3% |
| 2015 | 51.0% | +4.1% |
| 2016 | 54.0% | +5.9% |
| 2017 | 56.0% | +3.7% |
| 2018 | 55.0% | -1.8% |
| 2019 | 55.0% | +0.0% |
| 2020 | 55.0% | +0.0% |
| 2021 | 55.0% | +0.0% |
| 2022 | 55.0% | +0.0% |
| 2023 | 56.0% | +1.8% |
| 2024 | 57.0% | +1.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 44.3% | 43.0% | 47.0% | 10 |
| 2010s | 49.7% | 42.0% | 56.0% | 10 |
| 2020s | 55.6% | 55.0% | 57.0% | 5 |
Countries ranked near Greece
More gender data for Greece
- Child population (UN estimates and projections) 1,138 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -2.1 % change on previous year (2030)
- Population 8,584 (2030)
- Working-age population (UN estimates and projections) 8,584 (2030)
- Population (UN estimates and projections), annual growth rate -0.2295 % change on previous year (2030)
- Age population, age 00, female, interpolated 33,028 (2025)
- Age population, age 00, male, interpolated 35,271 (2025)
- Age population, age 01, female, interpolated 33,346 (2025)
- Age population, age 01, male, interpolated 35,681 (2025)
- Age population, age 02, female, interpolated 33,703 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Greece?
- Access to anti-retroviral drugs, female in Greece was 57.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Greece?
- The highest recorded value was 57.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Greece?
- The lowest recorded value was 42.0% in 2010.
- How does Greece rank for access to anti-retroviral drugs, female?
- Greece ranks 108th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Greece?
- Over the last ten years it is up 16.3%. The long-run trend across the full record is rising.
- Where does this Greece data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.